WAM
WX

Wolverine Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Wolverine Asset Management’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-68,155
Closed -$2.94M – 2081
2015
Q3 		$2.94M Buy
+68,155
New +$2.88M 0.07% 259

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Wolverine Asset Management's WX Position: Q4 2015 in Review

Wolverine Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 68,155 shares — an estimated $2.94M sold.

Wolverine Asset Management first reported a position in WX in Q3 2015 and held it in 1 quarter. The position peaked at $2.94M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Wolverine Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Wolverine Asset Management sold 68,155 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $2.94M.
  • Wolverine Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2015 and held it in 1 quarter.
  • Wolverine Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $2.94M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Wolverine Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.